Definium Therapeutics, Inc.
USD47.10
+0.55 (+1.18%)
CEO
Robert Barrow
IPO Date
2016-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$46.50
Prev. Close
$46.55
Day Low
$46.05
Day High
$49.20
52W Low
$12.88
52W High
$49.20
Market Cap
$5.14B
Volume
3.35M
| -4.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -122.5% | -76.9% | 0.18 | 3.22 | -1.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -37.6% | -33.4% | 0.00 | 8.16 | -1.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -61.3% | -56.7% | 0.00 | 13.18 | -6.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -44.9% | -41.8% | 0.00 | 27.10 | -23.8 |
| 31 Aug 2019 | FY | 0.0% | 0.0% | -40.8% | -38.0% | 0.00 | 14.76 | -0.2 |
| 31 Aug 2018 | FY | 0.0% | 0.0% | -24.3% | -24.3% | 0.00 | 24.14 | -0.5 |
| 31 Aug 2017 | FY | 0.0% | 0.0% | -31.1% | -30.5% | 0.00 | 22.03 | -1.2 |
| 31 Aug 2016 | FY | 0.0% | 0.0% | -141.3% | -88.7% | 0.00 | 1.80 | -1.5 |
| -5.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -51.5% | -28.4% | 0.31 | 3.30 | -3.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -23.1% | -16.1% | 0.22 | 4.98 | -3.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.5% | -8.5% | 0.10 | 7.27 | -5.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -14.4% | -11.5% | 0.09 | 7.25 | -4.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -5.2% | -4.3% | 0.09 | 9.00 | -8.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -2.9% | -2.2% | 0.12 | 5.92 | -21.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -27.7% | -19.7% | 0.07 | 3.91 | -2.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -30.5% | -19.2% | 0.18 | 3.22 | -1.5 |